Add
Compare:
Overview:
There are 20 differences and 1 similarities between Adderall, Strattera
| Basic Information |
| Generic Name |
| Amphetamine And Dextroamphetamine |
Atomoxetine |
| Class |
| Cns Stimulants |
Cns Stimulants |
| Prescription Generic Available |
| Yes |
No |
| Pregnancy cat. |
| C(us) |
B3(au) C(us) |
| Approved Age |
| 3 And Older |
6 And Older |
| Legal Status |
| Schedule I (ca) Schedule Ii (us) |
|
| WADA Category |
| S6 - Stimulants |
|
| Dependence Liability |
| High |
|
| Excretion |
| Urinary |
Renal (>80%) And Fecal ( |
| Possible Side Effects |
| Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
Sleep Problems, Anxiety, Fatigue, Upset Stomach, Dizziness, Dry Mouth. Rarely, Liver Damage |
|
| Dosage, Usage and Forms |
| Routes (of administration) |
| (medical) Oral, Insufflated, Intravenous |
Oral |
| Dosage |
| 5–30 Mg Bid Or 5–60 Mg Q
Am |
|
|
Maximum daily dose |
| 60 mg |
|
| Duration |
| Intermediate-acting |
Long-acting |
|
Duration - time |
| 4-8 H |
24 h |
| Chemical Data |
| Molecular mass (g/mol) |
| 135.21 G/mol |
255.36 G/mol
291.81 G/mol (hydrochloride) |
| Half Life |
| 10 Hours |
5 Hours |
| Formula |
| C9h13n |
C17h21no |
| Bioavailability |
| Nasal 75%; Rectal 95-99%; Intravenous 100% |
63-94% |
| Protein binding |
| 15-40% |
40 % |
| Metabolism |
| Hepatic |
Hepatic, Via Cyp2d6 |